ENHANCED DEPOSITION OF CHROMOGENS UTILIZING PYRIMIDINE ANALOGS
    1.
    发明申请
    ENHANCED DEPOSITION OF CHROMOGENS UTILIZING PYRIMIDINE ANALOGS 有权
    增强利福霉素类似物的色素沉积

    公开(公告)号:US20120171668A1

    公开(公告)日:2012-07-05

    申请号:US13339066

    申请日:2011-12-28

    IPC分类号: C12Q1/68 G01N33/536

    CPC分类号: G01N33/5306 G01N33/581

    摘要: This disclosure relates to compositions that enhance the deposition of detectable moieties on tissue samples, methods utilizing these compositions and kits including these compositions. The compositions include a deposition enhancer having a formula where R1, R2, R3, and R4 are independently selected from aliphatic, aryl, halogen, a heteroatom-containing moiety, and hydrogen; R1 and/or R3 can be bound to R2 to form a fused, aromatic ring system; R5 is selected from a heteroatom-containing moiety; A is selected from, a carbon atom, a heteroatom, other than sulfur, and any combination thereof; n is 1-5, an enzyme, a specific binding moiety and a detectable moiety.

    摘要翻译: 本公开涉及增强组织样品上可检测部分沉积的组合物,利用这些组合物的方法和包括这些组合物的试剂盒。 组合物包括具有下式的沉积增强剂:其中R 1,R 2,R 3和R 4独立地选自脂族,芳基,卤素,含杂原子的部分和氢; R 1和/或R 3可以与R 2结合形成稠合的芳环体系; R5选自含杂原子的部分; A选自碳原子,除硫以外的杂原子及其任意组合; n为1-5,酶,特异性结合部分和可检测部分。

    Enhanced deposition of chromogens
    2.
    发明授权
    Enhanced deposition of chromogens 有权
    增强沉积色原体

    公开(公告)号:US08871442B2

    公开(公告)日:2014-10-28

    申请号:US13339066

    申请日:2011-12-28

    IPC分类号: C12Q1/68 B01L3/00 G01N33/53

    CPC分类号: G01N33/5306 G01N33/581

    摘要: This disclosure relates to compositions that enhance the deposition of detectable moieties on tissue samples, methods utilizing these compositions and kits including these compositions. The compositions include a deposition enhancer having a formula where R1, R2, R3, and R4 are independently selected from aliphatic, aryl, halogen, a heteroatom-containing moiety, and hydrogen; R1 and/or R3 can be bound to R2 to form a fused, aromatic ring system; R5 is selected from a heteroatom-containing moiety; A is selected from, a carbon atom, a heteroatom, other than sulfur, and any combination thereof; n is 1-5, an enzyme, a specific binding moiety and a detectable moiety.

    摘要翻译: 本公开涉及增强组织样品上可检测部分沉积的组合物,利用这些组合物的方法和包括这些组合物的试剂盒。 组合物包括具有下式的沉积增强剂:其中R 1,R 2,R 3和R 4独立地选自脂族,芳基,卤素,含杂原子的部分和氢; R 1和/或R 3可以与R 2结合形成稠合的芳环体系; R5选自含杂原子的部分; A选自碳原子,除硫以外的杂原子及其任意组合; n为1-5,酶,特异性结合部分和可检测部分。

    HAPTEN CONJUGATES FOR TARGET DETECTION
    3.
    发明申请
    HAPTEN CONJUGATES FOR TARGET DETECTION 审中-公开
    寻找目标检测

    公开(公告)号:US20130109019A1

    公开(公告)日:2013-05-02

    申请号:US13805978

    申请日:2011-07-01

    摘要: Embodiments of hapten conjugates including a hapten, an optional linker, and a peroxidase-activatable aryl moiety are disclosed. In some embodiments, the peroxidase-activatable aryl moiety is tyramine or a tyramine derivative. Embodiments of methods for making and using the hapten conjugates also are disclosed. In particular embodiments, the hapten conjugates are used in a signal amplification assay. In certain embodiments, the hapten is an oxazole, a pyrazole, a thiazole, a benzofurazan, a triterpene, a urea, a thiourea other than a rhodamine thiourea, a nitroaryl other than dinitrophenyl or trinitrophenyl, a rotenoid, a cyclolignan, a heterobiaryl, an azoaryl, a benzodiazepine, or 7-diethylamino-3-carboxycoumarin. The hapten is coupled to the peroxidase-activatable aryl moiety directly or indirectly via a linker. In certain embodiments, the hapten conjugates are used in multiplexed assays.

    摘要翻译: 公开了包含半抗原,任选接头和过氧化物酶活化的芳基部分的半抗原共轭物的实施方案。 在一些实施方案中,过氧化物酶可活化的芳基部分是酪胺或酪胺衍生物。 还公开了制备和使用半抗原共轭物的方法的实施方案。 在具体实施方案中,半抗原共轭物用于信号放大测定。 在某些实施方案中,半抗原是恶唑,吡唑,噻唑,苯并呋咱,三萜,脲,除罗丹明硫脲以外的硫脲,除二硝基苯基或三硝基苯基以外的硝基芳基,旋环体,环链烷基,异二芳基, 偶氮二芳基,苯并二氮杂或7-二乙基氨基-3-羧基香豆素。 半抗原通过接头直接或间接地与过氧化物酶活化的芳基部分偶联。 在某些实施方案中,半抗原共轭物用于多重测定。